Fundraising Fox

Gilmartin Capital LLC

Venture capital

Larkspur · Series A–Late Stage · 2 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Gilmartin Capital invests in companies advancing platforms that address large or underserved diseases, technologies that accelerate scientific discovery, and solutions improving the cost, site, and delivery of care. The firm targets opportunities beyond proof of concept that are positioned for meaningful development and growth across the medical device, life science tool, diagnostic, and digital health sectors. Emphasizing insight over capital, Gilmartin offers domain expertise in strategy, market assessment, and capital markets advisory, drawing on a proprietary network of key opinion leaders and operators built over two decades. Much of its fund capital comes from healthcare operators.

Source: firm website, verified Aug 18, 2026.

Stage
Series A–Late Stage
HQ
Larkspur, US
Instruments
Equity
Founded
2021
Last 12 months
2 investments
Private fund assets
$61M
VC funds
1
Tracked investments
2

Team · 2 people

from the firm's website

What they invest in

from 2 of 2 portfolio companies

AI & Machine Learning ×1Biotech ×1EdTech ×1Enterprise Software ×1Future of Work ×1Healthtech ×1Medical Devices ×1

HQs:United States×2

Investments · 2 tracked

founders shown can be your intro path
Galvanizegalvanize.comin𝕏Sep 2025 · $100M

Galvanize provides customized technical education and training programs to help enterprise teams build skills in AI, machine learning, XP and Agile practices, data pipelines, and cloud operations.

AI & Machine LearningEdTechEnterprise SoftwareFuture of WorkDenver, US

Christopher C. Onan(Executive Officer)James Deters(President and Chief Executive Officer)Lawrence Mandes(Managing Director, New Markets)Tatiana Goldstein(Director)

BoardDaniel Pianko(Director)Jerrold Miller(Director)

Co-investorsTeamworthy VenturesThe Colorado Impact FundVTF CapitalAlly Bridge GroupCatalyst InvestorsFidelity Investments+5 more

Galvanize Therapeuticsgalvanizetx.cominSep 2025 · $100M

Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms.

BiotechHealthtechMedical DevicesRedwood City, US

Doug Godshall(Executive Officer, Director)Steve Anheier(Executive Officer)

BoardJonathan Waldstreicher(Executive Officer)Antoine Papiernik(Director)inSeth Harrison(Director)Zack Scott(Director)

Co-investorsNorwest Venture PartnersAlly Bridge GroupATPFidelity InvestmentsJanus Henderson InvestorsPerceptive Xontogeny Venture+2 more

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Gilmartin Capital LLC invest at?
Gilmartin Capital LLC invests at the Series A, Series B, Growth, Late Stage stages.
What sectors does Gilmartin Capital LLC focus on?
Gilmartin Capital LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Gilmartin Capital LLC located?
Gilmartin Capital LLC is headquartered in Larkspur, US.

Similar investors

Featured in lists